Optimized Fragmentation of Oligonucleotides Suppresses Undesired Fragmentation Products and Enables Confident Sequence Assignment

Optimized Fragmentation of Oligonucleotides by Low-q CID: Simplifying Spectra and Enhancing Sequence Confidence

Importance of the topic

Accurate tandem mass spectrometric sequencing of oligonucleotides is critical for RNA/DNA research, therapeutic oligonucleotide quality control, and characterization of modifications. Conventional vibrational activation methods frequently produce extensive secondary fragmentation (internal fragments and base losses) that confound spectral interpretation and reduce confidence in sequence assignments. Methods that reduce spectral complexity while preserving informative backbone cleavage products therefore improve throughput and reliability of oligonucleotide analysis.

Objectives and study overview

This work evaluates multiple vibrational and radical-based activation approaches for oligonucleotide fragmentation and introduces a modified ion-trap resonant CID workflow—low-q CID (lqCID)—that reduces the Mathieu q value during resonant excitation. The study compares lqCID with conventional CID, higher-energy collisional dissociation (HCD), infrared multiphoton dissociation (IRMPD), and electron-driven methods (NETD, AI-NETD, EPD) using model RNA oligomers (20mer, 50mer) to assess sequence coverage, spectral complexity, and false-positive fragment assignments. The ability of lqCID to act as a supplemental activation for odd-electron charge-reduced species (NETnoD/EPD products) is also examined.

Methodology and instrumentation used

Sample handling and ionization:

• Oligonucleotide standards reconstituted in MS-grade water and diluted to 10 µM in water or 50 mM ammonium acetate.
• Negative-mode static electrospray ionization from gold-coated pulled silica emitters.

Mass spectrometry platform and activation modes:

• Thermo Scientific Orbitrap Ascend Tribrid (with 213 nm UV laser) and a modified Orbitrap Eclipse Tribrid (enabled for IR activation in the linear ion trap).
• Quadrupole selection (2 Th windows) and MS2 acquisition in the linear ion trap (LIT) or HCD cell; product spectra recorded in the Orbitrap at high resolution (20mer: 120k; 50mer: 240k) with signal averaging.
• Activation methods and representative parameters: conventional trap CID (q=0.25, NCE ~30%, 10 ms), low-q CID (q=0.15, NCE ~20%, 30 ms), HCD (17% NCE), IRMPD (q=0.05, 3 W, 5 ms), NETD/AI-NETD (fluoranthene reagent, ~80 ms; AI-NETD: 1.5 W), and EPD (213 nm UV photodetachment).
• MS3 workflows: NET-lqCID and EPD-lqCID—isolated charge-reduced species dissociated using low-q CID (q=0.15) with tuned NCE (NET-lqCID ~15% NCE; EPD-lqCID ~10% NCE).

Data processing:

• Automated assignment for 20mers using BioPharma Finder (10 ppm tolerance, 0.5% intensity threshold); manual validation for NETD/EPD spectra and ions <2 kDa or with off-by-integer mass errors. 50mers deconvoluted using Zscape.

Main results and discussion

Key experimental observations:

• Lowering the Mathieu q to ~0.15 during trap CID (lqCID) reduces the maximum kinetic energy imparted per collision and narrows the accessible dissociation pathways. This selectively promotes primary backbone cleavages (first-generation sequence ions) while suppressing secondary fragmentation such as internal fragments and base losses.
• For a 20mer RNA, conventional HCD, CID and IRMPD produced many sequence-consistent c/y ions but also abundant false-positive c/y assignments arising from secondary fragmentation; HCD and CID generated multiple false c/y pairs for a scrambled control sequence. lqCID substantially reduced false-positive assignments—only a single low-intensity false y-ion was observed in the tested case.
• When used as supplemental activation for odd-electron charge-reduced products (NETnoD or EPD products), NET-lqCID and EPD-lqCID efficiently dissociated the intermediate intact products to produce complementary fragment series (d/w and a•/z• ions), improving coverage relative to NETD/AI-NETD alone.
• For larger oligonucleotides (50mer), both lqCID MS2 and NET-lqCID MS3 achieved near-complete series of informative backbone fragments. Spectral overlap among isotopic envelopes remained low, attributed to the reduced fragmentation channels and to the relatively low charge density/high m/z of large precursors.
• EPD-lqCID and NET-lqCID produced highly similar product-ion patterns; EPD-lqCID required slightly lower auxiliary amplitude to induce fragmentation, indicating practical interchangeability when appropriate instrumentation (213 nm laser) is available.

Benefits and practical applications of the method

• Reduced spectral complexity: lqCID biases fragmentation toward single backbone cleavages and first-generation products, markedly simplifying spectra and reducing ambiguous peak assignments.
• Improved sequence confidence: suppression of internal fragments and base-loss products lowers false-positive identifications and increases interpretability for both short and long oligonucleotides.
• Compatibility with odd-electron workflows: lqCID is effective as supplemental activation for NETD/EPD-derived charge-reduced species, enabling more complete MS3-based characterization strategies.
• Scalability to larger molecules: demonstrated performance on 50mers and indications of applicability up to 100mers or greater, relevant for long RNA analyses and some therapeutic oligonucleotides.
• Applicability to different analyte types: reported success for single-stranded DNA, modified RNAs, and varied charge states.

Future trends and potential applications

• Broader adoption in oligonucleotide QA/QC pipelines for therapeutic manufacturing, where reduced false positives accelerate release assays and identity/impurity profiling.
• Integration with automated data-analysis pipelines and dedicated spectral libraries that account for lqCID-specific fragment patterns to further increase throughput and reduce manual validation.
• Coupling lqCID with emerging radical-driven chemistries (AI-NETD, photodetachment) and optimized MS3 schemes to expand modification mapping and sequence resolution for highly modified oligonucleotides.
• Instrument development: commercialization of turnkey lqCID-capable methods and incorporation into acquisition software presets to ease method transfer between labs and platforms.
• Application to long-read oligonucleotide characterization, epi-transcriptomic studies, and analytical workflows for complex therapeutics (gapmers, siRNA, aptamers).

Conclusion

Reducing the trap Mathieu q during resonant CID (to ~0.15) constrains collision energy distribution and favors single backbone dissociation events. The resulting low-q CID (lqCID) spectra are substantially simpler and richer in first-generation sequence ions, enabling more confident and less ambiguous oligonucleotide sequencing across a range of sizes and charge states. lqCID also serves effectively as a supplemental activation step for odd-electron charge-reduced species (NETD/EPD workflows), producing complementary fragment series and improving coverage for challenging precursors. Overall, lqCID represents a practical, instrument-implementable strategy to improve tandem MS-based oligonucleotide characterization.

Reference

1. Huang T, et al. Journal of the American Society for Mass Spectrometry. 2008;19:1832–1840.
2. Gao Y, McLuckey SA. Rapid Communications in Mass Spectrometry. 2013:249–257.
3. Taucher M, Breuker K. Angewandte Chemie. 2012;124(45):11451–11454.
4. Peters-Clarke TM, et al. Analytical Chemistry. 2020;92(6):4436–4444.
5. Gabelica V, et al. Analytical Chemistry. 2006;78(18):6564–6572.
6. Yip P, et al. Methods for Data Dependent Mass Spectrometry of Mixed Protein Analysis. US Patent 10,217,619 B2, 2019.